MEDIUM confidence: 100% data completeness, but the composite (45) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
| Metric (USD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $264.0B— | $276.7B+4.8% | $309.0B+11.7% | $359.1B+16.2% | $403.4B+12.4% |
| EPS (dil.) | $7.23— | $25.04+246.3% | $22.39-10.6% | $25.72+14.9% | $38.38+49.2% |
| Free Cash Flow | $3.9B— | $4.6B+18.0% | $3.6B-21.2% | $5.2B+44.1% | $5.7B+9.4% |
| Gross Margin | 4.8% | 4.3%-0.5pp | 3.9%-0.3pp | 3.5%-0.5pp | 3.6%+0.1pp |
| Operating Margin | 1.0% | 1.6%+0.6pp | 1.3%-0.3pp | 1.2%-0.1pp | 1.6%+0.4pp |
| Net Margin | 0.4% | 1.3%+0.9pp | 1.0%-0.3pp | 0.9%-0.1pp | 1.2%+0.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Buy-rated share 83% → 82% over ~3 months (-1pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $9.56 | $9.93 | +3.9% |
| May 2026 | $11.56 | $11.69 | +1.1% |
| Feb 2026 | $9.17 | $9.34 | +1.9% |
| Nov 2025 | $9.03 | $9.86 | +9.2% |
| Aug 2025 | $8.14 | $8.26 | +1.5% |
| May 2025 | $9.83 | $10.12 | +3.0% |
| Feb 2025 | $8.60 | $8.03 | -6.6% |
| Nov 2024 | $6.88 | $7.07 | +2.8% |
Net insider -$23.9M over 180 days (0 open-market buys, 10 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 6.7%/yr (revenue basis).
Base free cash flow $4.9B (avg FY2024–FY2026; latest year $5.7B) · equity value $101.4B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 45 for McKesson Corporation suggests a neutral outlook, with the stock's strengths and weaknesses balancing out. The company scores high on growth, driven by strong revenue and EPS growth of 12.4% and 49.1%, respectively. However, its profitability score is dragged down by a negative ROE of -194.4%, while its value score is moderate due to a P/E of 23.1. The long-term and short-term scores are relatively aligned, with only a 2-point difference, indicating a consistent view of the stock's prospects.